Pfizer (PFE) Insider Makes Significant Share Sale

Thursday, September 14, 2017 10:15 PM ET

Pfizer (PFE) Insider Makes Significant Share Sale

There was a substantial insider sale of Pfizer shares today, as revealed in a filing with the SEC as — Sally Susman, Officer — sold 38,230 shares in the company having a market value of approximately $1,338,050 There have been 4 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been sales resulting in the sale of 426,291 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 464,521 shares and have averaged 92,904 shares per transaction over this time period.

Pfizer insider trading represents a higher number of buy/sell transactions than for the 112 peer company average over the last 90-day period. The Pharmaceuticals peer group saw 105 buy/sell trades during this period for an average of 0.9 transactions per company. The number of shares per buy/sell trade for Pfizer insiders was also higher. Within the peer group there were 3,002,918 shares purchased and 5,484,881 shares sold with company insiders selling 23,638 shares on average.

Insider buying and selling activity that is significant has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in composing and writing this story.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.